Prolonged infusion with β-lactam antibiotics for treatment of infection caused by non-susceptible bacteria: a study protocol for a systemic review and meta-analysis
- PMID: 31122992
- PMCID: PMC6538082
- DOI: 10.1136/bmjopen-2018-027509
Prolonged infusion with β-lactam antibiotics for treatment of infection caused by non-susceptible bacteria: a study protocol for a systemic review and meta-analysis
Abstract
Introduction: Prolonged infusion with β-lactam antibiotics should theoretically produce a better clinical efficacy than intermittent infusion in severe infection and infection caused by non-susceptible micro-organisms. The efficacy of prolonged infusion in severe infection has been well illustrated recently, but is still confusing in non-susceptible microbial infection. The objective of this meta-analysis is to determine the clinical effects of prolonged infusion with β-lactams for patients infected by microbes non-susceptible to the given drug.
Methods and analysis: Literature searches will be performed with Medline, the Cochrane database, EMBASE database, Cumulative Index to Nursing and Allied Health Literature database, the Chinese National Knowledge Infrastructure and Wanfang database. Two reviewers will screen and select studies according to a priori defined eligibility criteria, and then the data from the included studies will be extracted. The quality will be evaluated based on a modified Jadad score and the Newcastle-Ottawa system for randomised controlled trials and observational studies, respectively. Data synthesis will be performed with Review Manager 5.3 software. Sensitivity analysis and publication bias will also be investigated.
Ethics and dissemination: No ethics approval is required. The full article will be published in a peer-reviewed journal and presented at international conferences.
Prospero registration number: CRD42018105111.
Keywords: clinical pharmacology; infection control; infectious diseases; microbiology.
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Similar articles
-
Clinical and pharmacokinetic/dynamic outcomes of prolonged infusions of beta-lactam antimicrobials: An overview of systematic reviews.PLoS One. 2021 Jan 22;16(1):e0244966. doi: 10.1371/journal.pone.0244966. eCollection 2021. PLoS One. 2021. PMID: 33481817 Free PMC article.
-
Prolonged versus short-term intravenous infusion of antipseudomonal β-lactams for patients with sepsis: a systematic review and meta-analysis of randomised trials.Lancet Infect Dis. 2018 Jan;18(1):108-120. doi: 10.1016/S1473-3099(17)30615-1. Epub 2017 Nov 5. Lancet Infect Dis. 2018. PMID: 29102324
-
Prolonged infusion versus intermittent boluses of β-lactam antibiotics for treatment of acute infections: a meta-analysis.Int J Antimicrob Agents. 2014 May;43(5):403-11. doi: 10.1016/j.ijantimicag.2014.01.027. Epub 2014 Mar 1. Int J Antimicrob Agents. 2014. PMID: 24657044 Review.
-
Detailed regimens for the prolonged β-lactam infusion therapy.J Infect Chemother. 2024 Dec;30(12):1324-1326. doi: 10.1016/j.jiac.2024.07.003. Epub 2024 Jul 6. J Infect Chemother. 2024. PMID: 38977073
-
Prolonged infusion of beta-lactam antibiotics for Gram-negative infections: rationale and evidence base.Curr Opin Infect Dis. 2020 Dec;33(6):501-510. doi: 10.1097/QCO.0000000000000681. Curr Opin Infect Dis. 2020. PMID: 33009140 Review.
Cited by
-
Prolonged versus intermittent β-lactam antibiotics intravenous infusion strategy in sepsis or septic shock patients: a systematic review with meta-analysis and trial sequential analysis of randomized trials.J Intensive Care. 2020 Oct 6;8:77. doi: 10.1186/s40560-020-00490-z. eCollection 2020. J Intensive Care. 2020. PMID: 33042550 Free PMC article.
-
A Proposal for a Classification Guiding the Selection of Appropriate Antibiotic Therapy for Intra-Abdominal Infections.Antibiotics (Basel). 2022 Oct 12;11(10):1394. doi: 10.3390/antibiotics11101394. Antibiotics (Basel). 2022. PMID: 36290052 Free PMC article. Review.
References
-
- Kitamura Y, Yoshida K, Kusama M, et al. . A proposal of a pharmacokinetic/pharmacodynamic (PK/PD) index map for selecting an optimal PK/PD index from conventional indices (AUC/MIC, Cmax/MIC, and TAM) for antibiotics. Drug Metab Pharmacokinet 2014;29:455–62. 10.2133/dmpk.DMPK-14-RG-013 - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases